Kala Bio KALA
NASDAQ KALA
$0.82 -0.02 (-2.39%)
As of: Aug 21, 2026 · 3:58 PM EDT

Kala Bio (KALA) Accumulated Depreciation (2016 - 2025)

Kala Bio (KALA) posted Accumulated Depreciation of $869000.0 for Q4 2025, down 33.87% sequentially from $1.3 million in Q4 2024, and down 33.87% YoY from $1.3 million in Q4 2024.

Kala Bio (KALA) Accumulated Depreciation (2016 - 2025) Analysis & Trends

Kala Bio has reported Accumulated Depreciation for 10 years, with the latest figure at $869000.0 in Q4 2025.

  • Quarterly Accumulated Depreciation fell 33.87% year-over-year to $869000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $869000.0 (down 33.87% YoY) and the FY2025 annual result came in at $869000.0, down 33.87% from the prior year.
  • Accumulated Depreciation fell to $869000.0 in Q4 2025 per KALA's latest filing, from $1.3 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $2.9 million in Q4 2021 and troughed at $869000.0 in Q4 2025.
  • A 5-year average of $1.5 million and a median of $1.2 million in 2022 frame the typical range for Accumulated Depreciation.
  • The sharpest annual moves came in 2022 and 2024: Accumulated Depreciation slumped 57.22% in 2022, then gained 18.38% in 2024.
  • Over 5 years, Accumulated Depreciation stood at $2.9 million in 2021, then plunged by 57.22% to $1.2 million in 2022, then slipped by 9.31% to $1.1 million in 2023, then rose by 18.38% to $1.3 million in 2024, then plunged by 33.87% to $869000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation over the past three periods registered $869000.0, $1.3 million, and $1.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Kala Bio 9.89 Mn 9.89 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 869,000.00
Dec 31, 2024 1.31 Mn
Dec 31, 2023 1.11 Mn
Dec 31, 2022 1.22 Mn
Dec 31, 2021 2.86 Mn
Dec 31, 2020 3.42 Mn
Dec 31, 2019 2.52 Mn
Dec 31, 2018 1.82 Mn
Dec 31, 2017 1.54 Mn
Dec 31, 2016 1.32 Mn